Search

Your search keyword '"Beesley J"' showing total 983 results

Search Constraints

Start Over You searched for: Author "Beesley J" Remove constraint Author: "Beesley J"
983 results on '"Beesley J"'

Search Results

1. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

2. Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers

3. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

4. Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot".

5. Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium.

8. GFDL’s CM2 Global Coupled Climate Models. Part II : The Baseline Ocean Simulation

9. Large-scale cross-cancer fine-mapping of the 5p15.33 region reveals multiple independent signals

13. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

14. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

15. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

16. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature Communications, (2021), 12, 1, (1078), 10.1038/s41467-020-20496-3).

17. Mendelian randomisation study of smoking exposure in relation to breast cancer risk.

18. Erratum: Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature communications (2021) 12 1 (1078)).

19. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.

20. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

21. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.

22. Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.

23. Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer

24. Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis

25. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment

26. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (vol 12, 1078, 2021)

27. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

28. Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis

29. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment

30. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

36. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

37. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

38. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

39. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

40. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

41. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.

42. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

43. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

44. Non-coding RNAs underlie genetic predisposition to breast cancer

45. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.

46. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

47. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

48. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

49. Publisher Correction: Homologous recombination DNA repair defects in PALB2-associated breast cancers (npj Breast Cancer, (2019), 5, 1, (23), 10.1038/s41523-019-0115-9)

Catalog

Books, media, physical & digital resources